Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
324 Leser
Artikel bewerten:
(1)

NMS Consulting, Inc.: Dr. Ferkan Celik Joins NMS Consulting as a Managing Director and Partner

LOS ANGELES, CA / ACCESSWIRE / August 17, 2021 / NMS Consulting, Inc., a global management consulting and strategy firm, today announced the appointment of Dr. Ferkin Celik as a Managing Director and Partner based in the firm's Istanbul office.

Dr. Celik is a sought after advisor in academia and in the private and public sectors. Prior to joining NMS, she has worked with and advised multiple governments throughout Asia and has held senior positions within the Turkish Ministries of National Education, Industry and Trade, and Family and Social Policies. In these roles, she directly oversaw the creation, development, planning and implantation of many successful public and private-public programs, including the governmental program design and launch of more than 32 ministerial projects and 80 R&D centers.

Previously, Dr. Celik served on the Board of Directors of a Turkey based management consulting firm and was appointed as the Founding Partner and Chief Executive Officer of its research and development services division. In this role, she successfully completed the establishment of the Technology Transfer Office, the establishment of more than 150 R&D Centers, and 12 Turquality projects.

Prior experience also includes serving in Founding Director roles at Okan University and Yeditepe University for their Teknopark programs. She was directly responsible for the founding of the Technology Transfer Office which focused on university-industry cooperation within the organized industrial zones throughout Turkey.

"We are very excited to have Dr. Celik join NMS," stated Aykut Cakir, Senior Partner and Head of MENA Region at NMS. "Her background and experience are a perfect fit for the needs we are seeing from clients in the Middle East and Balkan regions, specifically for project management and public-private mandates. We are excited to be able to cater to more organizational needs, and to provide solutions for growing organizations in Turkey and in the Middle East as we continue to expand our team in the region."

Ms. Ferkan Celik, Managing Director and Partner at NMS stated "At NMS, I will be able to contribute to the growth of the company in the Balkan, Middle East and North Africa regions, particularly with project management, program design, and developing strategies. I have always been passionate about helping companies identify the best solutions for problems and roadblocks they are experiencing, and with NMS' staff, we will together be able to offer a wide range of skill sets and problem-solving techniques to clients."

Trevor M. Saliba, Managing Partner and Global Head of Private Equity, M&A and Strategy at NMS added, "I wish to welcome Dr. Celik to NMS Consulting and commend Aykut and the entire Istanbul team. The Istanbul team has exceeded all initial planning expectations for both new client mandates and now with the appointment of someone of Dr. Celik's caliber to our global team, we are seeing the positive impact NMS Consulting is making in Turkey and the surrounding region."

About NMS Consulting, Inc.

Founded in 2018, NMS Consulting is a global management consulting and strategic advisory firm that specializes in delivering services to a global client base of private and public companies, government agencies, philanthropic organizations and the individuals who lead them.

With a global footprint of fifteen offices located through the United States, Asia, Europe and the Middle East staffed with more than 250 seasoned professionals, our clients benefit from a combination of our diverse skills, expertise and global organization offering a unique multi-disciplinary 360° solutions platform.

Unlike other leading management consulting firms, NMS Consulting provides its clients the experience of working with a "big firm consultancy" without the higher premium. Client projects are staffed with qualified professionals who have trained at many of the leading global consultancy firms enabling the NMS professionals to deliver "big firm" experience and capabilities, while providing flexibility on mandate sizes and pricing.

Global Media Contacts:

USA - Lili Swanson
+1.310.855.0020
news@nmsconsulting.com

Europe - Sophia Binder
+49 30 8009 8742
sbinder@nmsconsulting.com

Istanbul / MENA - Gulcan Koseoglu
+90.216.970.3375
gulcank@nmsconsulting.com

SOURCE: NMS Consulting, Inc.



View source version on accesswire.com:
https://www.accesswire.com/659988/Dr-Ferkan-Celik-Joins-NMS-Consulting-as-a-Managing-Director-and-Partner

© 2021 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.